Video

Maintaining Adherence as Out of Pocket Costs Rise

Author(s):

Lauren Santye, Assistant Editor

Marc O'Connor, COO and Chief Strategy Officer at Curant Health, discusses how specialty pharmacy can help patients manage high out of pocket costs for specialty drugs.

Marc O'Connor, COO and Chief Strategy Officer at Curant Health, discusses how specialty pharmacy can help patients manage high out of pocket costs for specialty drugs.

Related Videos
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
Pharmacists working in a pharmacy -- Image credit: Drazen | stock.adobe.com
Young female pharmacist working in her large pharmacy. Placing medications, taking inventory. Lifestyle - Image credit: lubero | stock.adobe.com
Child with cancer -- Image credit: Alexis Scholtz/peopleimages.com | stock.adobe.com
Image Credit: © utah51 - stock.adobe.com
Image Credit: © Rawpixel.com - stock.adobe.com
Image Credit: © RandyJay - stock.adobe.com
Image Credit: © nimito - stock.adobe.com
Pharmacist helping patient -- Image credit: Clayton D/peopleimages.com | stock.adobe.com
Related Content
Marilyn Bulloch Doing Rounds in a Hospital With Physicians
October 14th 2024

Pharmacy Times Launches Behind The Script Campaign to Highlight Pharmacists

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Schizophrenia disorder and psychiatric disease or mental health as a psychiatry and psychology concept for human abnormal personality behavior and mood illness
October 14th 2024

Improving Schizophrenia Outcomes: The Role of Long-Acting Injectables and Medication Adherence

Brooke Kempf, PMHNP
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

Early Parkinson Disease and the Potential Therapeutic Role of Lixisenatide
October 11th 2024

Early Parkinson Disease and the Potential Therapeutic Role of Lixisenatide

Kamila Dymala, PharmD, MBA, BCMTMS, PACS
Exterior view of the headquarters of US Food and Drug Administration (FDA)
October 11th 2024

Facing Industry Disruptions, FDA Grants Temporary Exemption From DSCSA Requirements For Trading Partners

Luke Halpern, Assistant Editor